ROSEBIO
RoseBio is a biotechnology company focused on democratizing precision diagnostics for personalized medicine. They offer the ZipArray platform, a flexible and robust system for simultaneous and ultrasensitive detection of multiple rare biomarkers. Their technology enhances tissue profiling and enables informative liquid biopsies by analyzing challenging circulating biomarkers like cell-free nucleic acids and exosomes. RoseBio's initial focus areas are molecular oncology, infectious diseases, and drug resistance. The ZipArray platform integrates easily into existing laboratory infrastructure, allowing for re-configuration of probes and protocols with computational design. Their approach combines DNA-encoded arrays with signal enhancement and multiplexing capabilities, aiming for high sensitivity and rapid results. They are also implementing AI and digital technologies for further sensitivity improvements and interpretation support.
ROSEBIO
RoseBio is a biotechnology company focused on democratizing precision diagnostics for personalized medicine. They offer the ZipArray platform, a flexible and robust system for simultaneous and ultrasensitive detection of multiple rare biomarkers. Their technology enhances tissue profiling and enables informative liquid biopsies by analyzing challenging circulating biomarkers like cell-free nucleic acids and exosomes. RoseBio's initial focus areas are molecular oncology, infectious diseases, and drug resistance. The ZipArray platform integrates easily into existing laboratory infrastructure, allowing for re-configuration of probes and protocols with computational design. Their approach combines DNA-encoded arrays with signal enhancement and multiplexing capabilities, aiming for high sensitivity and rapid results. They are also implementing AI and digital technologies for further sensitivity improvements and interpretation support.